{"owner_org": "8b28b117-7f89-4fd7-b4b2-98a7b01d5529", "maintainer": null, "relationships_as_object": [], "data_dict": "{\"license_title\": \"\", \"maintainer\": null, \"relationships_as_object\": [], \"private\": false, \"maintainer_email\": null, \"num_tags\": 0, \"id\": \"5e4c83d4-9078-4f94-b09b-770af43c08bd\", \"metadata_created\": \"2013-09-02T22:03:53.605003\", \"metadata_modified\": \"2013-09-02T22:03:53.605003\", \"author\": null, \"author_email\": null, \"state\": \"active\", \"version\": null, \"license_id\": \"\", \"type\": \"dataset\", \"resources\": [], \"num_resources\": 0, \"tags\": [], \"tracking_summary\": {\"total\": 0, \"recent\": 0}, \"groups\": [], \"organization\": {\"description\": \"\", \"title\": \"Veterinary Medicines Directorate\", \"created\": \"2012-06-27T14:54:46.037910\", \"approval_status\": \"approved\", \"revision_timestamp\": \"2012-06-27T13:48:36.948477\", \"is_organization\": true, \"state\": \"active\", \"image_url\": \"\", \"revision_id\": \"a1f4375a-4afe-4dad-88cd-03f2bd6adaaf\", \"type\": \"organization\", \"id\": \"8b28b117-7f89-4fd7-b4b2-98a7b01d5529\", \"name\": \"veterinary-medicines-directorate\"}, \"relationships_as_subject\": [], \"revision_timestamp\": \"2013-09-02T22:03:53.605003\", \"name\": \"periodic-safety-update-reports-from-marketing-authorisation-holders-about-pharmacovigilance-dat\", \"isopen\": false, \"url\": null, \"notes\": \"Documents submitted by companies as part of their regulatory obligations, summarising all adverse events reported in a predefined period.\", \"owner_org\": \"8b28b117-7f89-4fd7-b4b2-98a7b01d5529\", \"extras\": [{\"state\": \"active\", \"value\": \"\", \"revision_timestamp\": \"2013-09-02T22:03:53.605003\", \"package_id\": \"5e4c83d4-9078-4f94-b09b-770af43c08bd\", \"key\": \"publish-date\", \"revision_id\": \"8f24d0d2-132c-4263-893d-6834c815a406\", \"id\": \"70f70e94-6b0f-4cc4-9b24-2b9ca67b23c6\"}, {\"state\": \"active\", \"value\": \"As well as listing all the reports, the companies provide us with sales data in order to allow the calculation of incidence of adverse events.This information is confidential, although the resulting incidence figures obtained using this information provide a useful way to communicate relative risks which we will be utilising.\", \"revision_timestamp\": \"2013-09-02T22:03:53.605003\", \"package_id\": \"5e4c83d4-9078-4f94-b09b-770af43c08bd\", \"key\": \"release-notes\", \"revision_id\": \"8f24d0d2-132c-4263-893d-6834c815a406\", \"id\": \"8c013dae-4e70-4c23-9e8b-026135574fc8\"}, {\"state\": \"active\", \"value\": \"true\", \"revision_timestamp\": \"2013-09-02T22:03:53.605003\", \"package_id\": \"5e4c83d4-9078-4f94-b09b-770af43c08bd\", \"key\": \"unpublished\", \"revision_id\": \"8f24d0d2-132c-4263-893d-6834c815a406\", \"id\": \"7d66d330-d12b-46e1-854d-8239ce8939ce\"}], \"title\": \"Periodic Safety Update Reports from Marketing Authorisation holders about pharmacovigilance data on their products\", \"revision_id\": \"8f24d0d2-132c-4263-893d-6834c815a406\"}", "private": false, "maintainer_email": null, "num_tags": 0, "id": "5e4c83d4-9078-4f94-b09b-770af43c08bd", "metadata_created": "2013-09-02T22:03:53.605003", "metadata_modified": "2013-09-02T22:03:53.605003", "author": null, "author_email": null, "state": "active", "version": null, "license_id": "", "type": "dataset", "unpublished": "true", "resources": [], "num_resources": 0, "tags": [], "title": "Periodic Safety Update Reports from Marketing Authorisation holders about pharmacovigilance data on their products", "release-notes": "As well as listing all the reports, the companies provide us with sales data in order to allow the calculation of incidence of adverse events.This information is confidential, although the resulting incidence figures obtained using this information provide a useful way to communicate relative risks which we will be utilising.", "publish-date": "", "groups": [], "relationships_as_subject": [], "revision_timestamp": "2013-09-02T22:03:53.605003", "name": "periodic-safety-update-reports-from-marketing-authorisation-holders-about-pharmacovigilance-dat", "isopen": false, "url": null, "notes": "Documents submitted by companies as part of their regulatory obligations, summarising all adverse events reported in a predefined period.", "license_title": "", "tracking_summary": {"total": 0, "recent": 0}, "extras": [{"state": "active", "value": "", "revision_timestamp": "2013-09-02T22:03:53.605003", "package_id": "5e4c83d4-9078-4f94-b09b-770af43c08bd", "key": "publish-date", "revision_id": "8f24d0d2-132c-4263-893d-6834c815a406", "id": "70f70e94-6b0f-4cc4-9b24-2b9ca67b23c6"}, {"state": "active", "value": "As well as listing all the reports, the companies provide us with sales data in order to allow the calculation of incidence of adverse events.This information is confidential, although the resulting incidence figures obtained using this information provide a useful way to communicate relative risks which we will be utilising.", "revision_timestamp": "2013-09-02T22:03:53.605003", "package_id": "5e4c83d4-9078-4f94-b09b-770af43c08bd", "key": "release-notes", "revision_id": "8f24d0d2-132c-4263-893d-6834c815a406", "id": "8c013dae-4e70-4c23-9e8b-026135574fc8"}, {"state": "active", "value": "true", "revision_timestamp": "2013-09-02T22:03:53.605003", "package_id": "5e4c83d4-9078-4f94-b09b-770af43c08bd", "key": "unpublished", "revision_id": "8f24d0d2-132c-4263-893d-6834c815a406", "id": "7d66d330-d12b-46e1-854d-8239ce8939ce"}], "organization": {"description": "", "created": "2012-06-27T14:54:46.037910", "title": "Veterinary Medicines Directorate", "name": "veterinary-medicines-directorate", "revision_timestamp": "2012-06-27T13:48:36.948477", "is_organization": true, "state": "active", "image_url": "", "revision_id": "a1f4375a-4afe-4dad-88cd-03f2bd6adaaf", "type": "organization", "id": "8b28b117-7f89-4fd7-b4b2-98a7b01d5529", "approval_status": "approved"}, "revision_id": "8f24d0d2-132c-4263-893d-6834c815a406"}